SOPHiA GENETICS SA financial data

Symbol
SOPH on Nasdaq
Location
Rolle, Switzerland
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 04 Mar 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 66,687,085 shares 2.2%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense $7,958,000 USD -10%
General And Administrative Expense $10,583,000 USD -25%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets $155,309,000 USD -25%
Liabilities $58,819,000 USD 7.5%